LDLR and familial pancreatic carcinoma: Current research has not only revealed the correlation between the progression and drug resistance of pancreatic cancer and cholesterol but also demonstrated that tumors increase the uptake of exogenous cholesterol by increasing LDL receptors on the surface of cancer cells so as to meet their high avidity for cholesterol [23].